Bill Gurley · Forbes · 21 April 2026
“A lot of drug companies end up focused on symptom support rather than solving it because there's more money in that, and unfortunately, that's less, you know, it'd be much better if we cured the disease.”
Verbatim excerpt with a timestamp. The full recording is at the source; we link out and do not host it. Everything Bill Gurley is on record saying.